Insider Transactions in Q2 2022 at Verona Pharma PLC (VRNA)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 22
2022
|
Claire Poll General Counsel |
BUY
Bona fide gift
|
Indirect |
90,104
+10.67%
|
-
|
|
May 22
2022
|
Claire Poll General Counsel |
SELL
Bona fide gift
|
Direct |
90,104
-3.78%
|
-
|
|
May 03
2022
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,512
-0.08%
|
$0
$0.5 P/Share
|
|
May 03
2022
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
28,752
-1.15%
|
$0
$0.49 P/Share
|
|
May 03
2022
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
32,904
-0.2%
|
$0
$0.5 P/Share
|
|
May 01
2022
|
David Zaccardelli President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
454,864
-2.7%
|
$0
$0.52 P/Share
|
|
May 01
2022
|
Mark W Hahn Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
432,128
-2.73%
|
$0
$0.52 P/Share
|
|
May 01
2022
|
Claire Poll General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
79,896
-4.16%
|
$0
$0.52 P/Share
|
|
May 01
2022
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
56,432
-2.22%
|
$0
$0.52 P/Share
|
|
Apr 11
2022
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
59,720
-2.29%
|
$0
$0.54 P/Share
|
|
Apr 08
2022
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
112,800
-4.15%
|
$0
$0.59 P/Share
|